Vice President of
Chin-Yin studied at Chinese Culture University, UConn and UMass Medical School. She received a Ph.D. degree in Cell Biology from UMass Medical School, and went through her postdoctoral training in neurobiology at Caltech from 2002-2008. She then returned to Taiwan and joined the Institute of Molecular Biology, Academia Sinica, as an assistant research fellow to elucidate the molecular mechanism of neuronal adhesion molecule in synaptic plasticity from 2008-2015. Chin-Yin joined the Development Center for Biotechnology (DCB) to set up the drug discovery capabilities of neurodegenerative diseases in mid-2015, and served as the acting director of Translational Medicine Laboratory to facilitate the collaboration between the industry and the medical centers in mid-2016. During her tenure at DCB, Chin-Yin led drug discovery projects in AD and ALS. She also built a collaborative exploration program between physicians and DCB researchers to validate the potential drug targets in several cancers. In 2017, Chin-Yin joined APRIONIA as the Vice President of Neurobiology to continue her scientific endeavor in neuroscience and drug discovery.